Soleus Capital Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,600	Closed	-$461K	–	98
2023 Q2	$461K	Buy	+13,600	New	+$461K	0.05%	96
2022 Q2	–	Sell	-69,000	Closed	-$2.35M	–	72
2022 Q1	$2.35M	Buy	+69,000	New	+$2.35M	0.3%	51